275 related articles for article (PubMed ID: 15805112)
1. Spatiotemporal switch from DeltaNp73 to TAp73 isoforms during nephrogenesis: impact on differentiation gene expression.
Saifudeen Z; Diavolitsis V; Stefkova J; Dipp S; Fan H; El-Dahr SS
J Biol Chem; 2005 Jun; 280(24):23094-102. PubMed ID: 15805112
[TBL] [Abstract][Full Text] [Related]
2. DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors.
Zaika AI; Slade N; Erster SH; Sansome C; Joseph TW; Pearl M; Chalas E; Moll UM
J Exp Med; 2002 Sep; 196(6):765-80. PubMed ID: 12235210
[TBL] [Abstract][Full Text] [Related]
3. p73, a sophisticated p53 family member in the cancer world.
Ozaki T; Nakagawara A
Cancer Sci; 2005 Nov; 96(11):729-37. PubMed ID: 16271066
[TBL] [Abstract][Full Text] [Related]
4. p73 plays a role in erythroid differentiation through GATA1 induction.
Marqués-García F; Ferrandiz N; Fernández-Alonso R; González-Cano L; Herreros-Villanueva M; Rosa-Garrido M; Fernández-García B; Vaque JP; Marqués MM; Alonso ME; Segovia JC; León J; Marín MC
J Biol Chem; 2009 Aug; 284(32):21139-56. PubMed ID: 19509292
[TBL] [Abstract][Full Text] [Related]
5. Mdm2-mediated NEDD8 modification of TAp73 regulates its transactivation function.
Watson IR; Blanch A; Lin DC; Ohh M; Irwin MS
J Biol Chem; 2006 Nov; 281(45):34096-103. PubMed ID: 16980297
[TBL] [Abstract][Full Text] [Related]
6. Negative autoregulation of p73 and p53 by DeltaNp73 in regulating differentiation and survival of human neuroblastoma cells.
Nakagawa T; Takahashi M; Ozaki T; Watanabe K; Hayashi S; Hosoda M; Todo S; Nakagawara A
Cancer Lett; 2003 Jul; 197(1-2):105-9. PubMed ID: 12880968
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of TAp73 and ΔNp73 protein expression in ovarian cancer: a series of 83 cases and review of the literature.
Hofstetter G; Berger A; Chamson M; Müller-Holzner E; Reimer D; Ulmer H; Uramoto H; Marth C; Zeimet AG; Zeillinger R; Concin N
Int J Gynecol Pathol; 2011 Nov; 30(6):527-31. PubMed ID: 21979586
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of p63 and p73 expression.
Waltermann A; Kartasheva NN; Dobbelstein M
Oncogene; 2003 Aug; 22(36):5686-93. PubMed ID: 12944917
[TBL] [Abstract][Full Text] [Related]
9. Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo.
Concin N; Becker K; Slade N; Erster S; Mueller-Holzner E; Ulmer H; Daxenbichler G; Zeimet A; Zeillinger R; Marth C; Moll UM
Cancer Res; 2004 Apr; 64(7):2449-60. PubMed ID: 15059898
[TBL] [Abstract][Full Text] [Related]
10. Differential control of TAp73 and DeltaNp73 protein stability by the ring finger ubiquitin ligase PIR2.
Sayan BS; Yang AL; Conforti F; Tucci P; Piro MC; Browne GJ; Agostini M; Bernardini S; Knight RA; Mak TW; Melino G
Proc Natl Acad Sci U S A; 2010 Jul; 107(29):12877-82. PubMed ID: 20615966
[TBL] [Abstract][Full Text] [Related]
11. TAp73 and ΔNp73 have opposing roles in 5-aza-2'-deoxycytidine-induced apoptosis in breast cancer cells.
Lai J; Yang F; Zhang W; Wang Y; Xu J; Song W; Huang G; Gu J; Guan X
Mol Cells; 2014 Aug; 37(8):605-12. PubMed ID: 25134538
[TBL] [Abstract][Full Text] [Related]
12. p73 induces apoptosis by different mechanisms.
Ramadan S; Terrinoni A; Catani MV; Sayan AE; Knight RA; Mueller M; Krammer PH; Melino G; Candi E
Biochem Biophys Res Commun; 2005 Jun; 331(3):713-7. PubMed ID: 15865927
[TBL] [Abstract][Full Text] [Related]
13. Possible oncogenic potential of DeltaNp73: a newly identified isoform of human p73.
Ishimoto O; Kawahara C; Enjo K; Obinata M; Nukiwa T; Ikawa S
Cancer Res; 2002 Feb; 62(3):636-41. PubMed ID: 11830511
[TBL] [Abstract][Full Text] [Related]
14. deltaNp73 facilitates cell immortalization and cooperates with oncogenic Ras in cellular transformation in vivo.
Petrenko O; Zaika A; Moll UM
Mol Cell Biol; 2003 Aug; 23(16):5540-55. PubMed ID: 12897129
[TBL] [Abstract][Full Text] [Related]
15. One, two, three--p53, p63, p73 and chemosensitivity.
Müller M; Schleithoff ES; Stremmel W; Melino G; Krammer PH; Schilling T
Drug Resist Updat; 2006 Dec; 9(6):288-306. PubMed ID: 17287142
[TBL] [Abstract][Full Text] [Related]
16. Involvement of N-terminally truncated variants of p73, deltaTAp73, in head and neck squamous cell cancer: a comparison with p53 mutations.
Faridoni-Laurens L; Tourpin S; Alsafadi S; Barrois M; Temam S; Janot F; Koscielny S; Bosq J; Bénard J; Ahomadegbe JC
Cell Cycle; 2008 Jun; 7(11):1587-96. PubMed ID: 18469517
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of the p73 gene by Nrf-2 and promoter CpG methylation in human breast cancer.
Lai J; Nie W; Zhang W; Wang Y; Xie R; Wang Y; Gu J; Xu J; Song W; Yang F; Huang G; Cao P; Guan X
Oncotarget; 2014 Aug; 5(16):6909-22. PubMed ID: 25071010
[TBL] [Abstract][Full Text] [Related]
18. Multiple isoforms of the tumor protein p73 are expressed in the adult human telencephalon and choroid plexus and present in the cerebrospinal fluid.
Cabrera-Socorro A; Pueyo Morlans M; Suarez Sola ML; Gonzalez Delgado FJ; Castañeyra-Perdomo A; Marin MC; Meyer G
Eur J Neurosci; 2006 Apr; 23(8):2109-18. PubMed ID: 16630058
[TBL] [Abstract][Full Text] [Related]
19. The transcriptional repressor ZEB regulates p73 expression at the crossroad between proliferation and differentiation.
Fontemaggi G; Gurtner A; Strano S; Higashi Y; Sacchi A; Piaggio G; Blandino G
Mol Cell Biol; 2001 Dec; 21(24):8461-70. PubMed ID: 11713281
[TBL] [Abstract][Full Text] [Related]
20. Combinatorial control of the bradykinin B2 receptor promoter by p53, CREB, KLF-4, and CBP: implications for terminal nephron differentiation.
Saifudeen Z; Dipp S; Fan H; El-Dahr SS
Am J Physiol Renal Physiol; 2005 May; 288(5):F899-909. PubMed ID: 15632413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
